CRNX
Crinetics Pharmaceuticals Inc.
$45.91
+$10.02(+27.92%)
40
Overall
--
Value
40
Tech
--
Quality
Market Cap
$3.19B
Volume
10.22M
52W Range
$24.10 - $62.53
Target Price
$69.63
EPS Estimates Overview
| Current Quarter | $-1.25 | Next Quarter | $-1.3 |
| Current Year | $-4.79 | Next Year | $-5.24 |
| QoQ Growth | -4.0% | YoY Growth | -9.4% |
| 3Y EPS CAGR | -9.6% | Target Price | $69.63 |
| Consensus | Buy | Upside | +51.7% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRNX | $45.91 | +27.9% | 10.22M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Crinetics Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW